InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Glover Steve C, Director. Officer active across 1 company, notably PDS Biotechnology Corp. Aggregated, 2 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €82k. Activity tracked since 15 June 2021. The latest transaction was disclosed on 15 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
5,882 shares@ US$8.5050.0% of flowCommon StockSEC:0001140361-21-021499
Ideal exit: 12 Mar 2022 (T+270)
5,882 shares@ US$8.500.098% mcap50.0% of flowCommon StockSEC:0001140361-21-021499:0
Ideal exit: 12 Mar 2022 (T+270)
2 of 2 declarations
About Glover Steve C
Steve C. Glover is a Board Member at PDS Biotechnology Corp. He brings expertise in biotechnology and business development to the board. His experience in the pharmaceutical sector contributes to guiding the strategic decisions of the company.
